| Product Name |
MF |
CAS |
Details |
| Nabumetone
4-(6-methoxynaphthalen-2-yl)butan-2-one |
C15H16O2 |
42924-53-8 |
|
| Leflunomide EP Impurity A
Leflunomide USP RC A ; 4-(trifluoromethyl)aniline |
C7H6F3N |
455-14-1 |
|
| Levodopa
(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
C9H11NO4 |
59-92-7 |
|
| Meloxicam EP Impurity A
Meloxicam USP Related Compound A ;
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
C12H13NO5S |
24683-26-9 |
|
| Piroxicam EP Impurity K
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide |
C12H13NO5S |
24683-26-9 |
|
| Closantel EP Impurity A
2-Hydroxy-3,5-diiodobenzoic acid |
C7H4I2O3 |
133-91-5 |
|
| Gabapentin EP Impurity A
Gabapentin USP Related Compound A ; Gabapentin Lactam ; 3-Azaspiro-[4,5]decan-3-one |
C9H15NO |
64744-50-9 |
|
| Rabeprazole Sodium
Sodium 2-[[4-(3-methoxypropoxy)-3-methyl-pyridin-2- yl]methylsulfinyl
]benzoimidazole |
C18H20N3NaO3S |
117976-90-6 |
|
| Ondansetron EP Impurity C
9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one |
C13H13NO |
27387-31-1 |
|
| Memantine Related Compound C
(1r,3R,5S,7r)-1-chloro-3,5-dimethyladamantane |
C12H19Cl |
707-36-8 |
|
| Prasugrel Bromobutyryl Impurity
5-(5-bromo-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7- tetrahydrothieno[3,2-c]
pyridin-2-yl acetate |
C20H21BrFNO3S |
1373350-59-4 |
|
| ketoprofen EP impurity D
2-(3-(4-methylbenzoyl)phenyl)propanoic acid |
C17H16O3 |
107257-20-5 |
|
| Olmesartan Imidazole Diacid Impurity
2-Propyl-1H-imidazole-4,5-dicarboxylic acid |
C8H10N2O4 |
58954-23-7 |
|
| Lacosamide EP Impurity L
(R)-2-(Acetylamino)-3-methoxy-N-methyl-N-(phenylmethyl)-
propanamide |
C14H20N2O3 |
388619-64-5 |
|
| Azithromycin EP Impurity
B(2R,3R,4S,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-
methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-4,10- dihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3- (dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-1-Oxa-6- |
C38H72N2O11 |
307974-61-4 |
|
| Alfuzosin Aminopropyl Impurity ; Alfuzosin USP Related
Compound D |
C14H22ClN5O2 |
81403-69-2 |
|
| Telmisartan Bromo Nitrile Impurity
4'-(Bromomethyl)-[1,1'-biphenyl]-2-carbonitrile ; 2-(4- Bromomethylphenyl)
benzonitrile |
C14H10BrN |
114772-54-2 |
|
| Irbesartan Bromo Nitrile Impurity
4'-(Bromomethyl)biphenyl-2-carbonitrile |
C14H10BrN |
114772-54-2 |
|
| Atenolol EP Impurity C
2-[4-[[(2RS)-oxiran-2-yl]methoxy]phenyl]acetamide |
C11H13NO3 |
29122-69-8 |
|
| Isobutyl-glutamonoamide
(R)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid |
C9H17NO3 |
181289-33-8 |
|
| Emtricitabine SM
5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2 carboxylic acid 5-methyl-2-(1-methylethyl)cyclohexyl ester |
C18H26FN3O4S |
147126-75-8 |
|
| Metamizole EP Impurity A
4-(formylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol- 3-one ; 4-Formylamino Antipyrine |
C12H13N3O2 |
1672-58-8 |
|
| Fenticonazole Nitrate EP Impurity E
3-(2-(2,4-dichlorophenyl)-2-((4-(phenylthio)benzyl)oxy)ethyl)-1-
(4-(phenylthio)benzyl)-1H-imidazol-3-ium Hydrochloride |
C37H31Cl2N2OS2+ |
756429-44-4 |
|
| Mesalazine EP Impurity J
3,5-diamino-2-hydroxybenzoic acid (3,5-diaminosalicylic acid).; Mesalamine EP Impurity J |
C7H8N2O3 |
112725-89-0 |
|
| Dabigatran Methylamino Impurity |
C18H22N4O3 |
212322-56-0 |
|
| Lisinopril Dihydrate
(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline Dihydrate |
C21H33N3O6 |
83915-83-7 |
|
| Gabapentin EP Impurity E
Gabapentin USP Related Compound E ;
Gabapentin Diacid ; 1-(carboxymethyl)cyclohexanecarboxylic acid |
C9H14O4 |
67950-95-2 |
|
| Lisinopril EP Impurity C
S,S,S-Diketopiperazine (lisinopril related compound A) |
C21H29N3O4 |
328385-86-0 |
|
| Haloperidol Impurity 8
Chloro-fluoro-butyrophenone ; 4-chloro-1-(4- fluorophenyl)butan-1-one; 3-(4-Fluorophenylcarbonyl)-1- chloropropane |
C10H10ClFO |
3874-54-2 |
|
| Sitagliptin Triazole Hydrochloride
Sitagliptin Impurity 20 HCl;
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-
a]pyrazine hydrochloride |
C6H7F3N4.ClH |
762240-92-6 |
|
| Moxifloxacin EP Impurity A
Moxifloxacin USP RC A ; 8-Desmethoxy-8-Fluoro Moxifloxacin ;
Moxifloxacin Difluoro Analog |
C20H21F2N3O3 |
151213-15-9 |
|
| Fexofenadine EP Impurity E
diphenyl(piperidin-4-yl)methanol |
C18H21NO |
115-46-8 |
|
| Glimepiride EP Impurity B
USP Glimepiride Related Compound B ; Glimepiride Sulfonamide |
C16H21N3O4S |
119018-29-0 |
|
| Closantel EP Impurity B
(2RS)-(4-Amino-2-chloro-5-methylphenyl)(4- chlorophenyl)ethanenitril |
C15H12Cl2N2 |
61437-85-2 |
|
| Olanzapine EP Impurity A
Olanzapine USP RC A ; 5-methyl-2-((2-
nitrophenyl)amino)thiophene-3-carbonitrile |
C12H9N3O2S |
138564-59-7 |
|
| Prasugrel Impurity 12
2-bromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one |
C11H10BrFO |
204205-33-4 |
|
| Bisoprolol Carboxylic Acid Impurity
4-(2-Hydroxy-3-isopropylaminopropoxy)benzoic Acid |
C13H19NO4 |
72570-70-8 |
|
| Moxifloxacin HCl
1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H- pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3- carboxylic acid hydrochloride |
C21H25ClFN3O4 |
186826-86-8 |
|
| Candesartan Cilexetil
1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H- tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-
carboxylate |
C33H34N6O6 |
145040-37-5 |
|
| Omeprazole EP Impurity XI
2-Chloromethyl-3,5-dimethyl-4-methoxypyridine HCl |
C9H13Cl2NO |
86604-75-3 |
|
| Chlortalidone
2-Chloro-5-(1-hydroxy-3-oxo-1-
isoindolinyl)benzenesulfonamide |
C14H11ClN2O4S |
77-36-1 |
|
| Cetirizine 4-Chlorobenzophenone Impurity (USP)
(4-Chlorophenyl)phenylmethanone |
C13H9ClO |
134-85-0 |
|
| Piroxicam EP Impurity F
1-Methylethyl (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-
yl)acetate |
C12H13NO5S |
76508-37-7 |
|
| Metronidazole EP impurity C
2-(4-nitro-1H-imidazol-1-yl)ethan-1-ol |
C5H7N3O3 |
5006-69-9 |
|
| Olmesartan EP Impurity C
Dehydro Olmesartan Medoxomil ; Anhydro Olmesartan
Medoxomil ; Olmesartan Medoxomil Olefinic Impurity (USP) |
C29H28N6O5 |
879562-26-2 |
|
| Amlodipine EP Impurity F
Amlodipine Dimethyl Ester; 2-[(2-Aminoethoxy)methyl]-4-(2- chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic Acid 3,5-dimethyl Ester |
C19H23ClN2O5 |
140171-66-0 |
|
| Olmesartan Medoxomil Methyl Ether
Olmesartan Medoxomil O-Methyl Analog |
C30H32N6O6 |
896419-17-3 |
|
| Apixaban ethyl ester impuity
Ethyl 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-
yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3- carboxylate |
C27H28N4O5 |
503614-91-3 |
|
| Fenticonazole Nitrate EP Impurity C
1-(2-(2,4-dichlorophenyl)-2-((4- (phenylsulfonyl)benzyl)oxy)ethyl)-1H-imidazole |
C24H21Cl2N3O6S |
80676-29-5 |
|
| 2-Amino-5-methyl-3-thiophenecarbonitrile |
C6H6N2S |
138564-58-6 |
|
| Alfuzosin EP Impurity A
Alfuzosin USP Related Compound A ; Alfuzosin Tetradehydro
Impurity |
C19H24ClN5O4 |
98902-29-5 |
|
| Isosorbide Mononitrate
1,4:3,6-Dianhydro-D-glucitol 5-Nitrate,Isosorbide 5- Mononitrate |
C6H9NO6 |
16051-77-7 |
|
| Telmisartan EP Impurity B
Telmisartan USP Related Compound B ; Telmisartan Isomer |
C33H30N4O2 |
1026353-20-7 |
|
| Guanine
2-amino-9H-purin-6(1H)-one |
C5H5N5O |
73-40-5 |
|
| Valaciclovir EP Impurity A/ Valganciclovir related compound B
Valganciclovir related compound B, A ciclovir EP Impurity B ; Guanine |
C5H5N5O |
73-40-5 |
|
| Lansoprazole Sulfide N-Oxide
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]- 1H-benzimidazole N-Oxide |
C16H14F3N3O2S |
163119-30-0 |
|
| Desloratadine EP Impurity A
Desloratadine EP Impurity A ; 11-Fluoro Dihydrodesloratadine |
C19H20ClFN2 |
298220-99-2 |
|
| Aripiprazole Related Compound B
3,4-Dihydro-7-(4-hydroxybutoxy)-2(1H)-quinolinone |
C13H17NO3 |
889443-20-3 |
|
| Memantine Related Compound E
N-((1r,3R,5S,7r)-3,5-dimethyladamantan-1-yl)formamide |
C13H21NO |
351329-88-9 |
|
| Gabapentin
1-(Aminomethyl)cyclohexaneacetic acid |
C9H17NO2 |
60142-96-3 |
|
| Prucalopride impurity A
4-amino-5-chloro2,3-dihydro-N(piperidin4-yl) benzofuran - 7carboxamide |
C14H18ClN3O2 |
137211-64-4 |
|
| 3-(4-Chlorophenyl)-1-isoindolinone
3-(p-Chlorophenyl)-phthalimidine; 3-(4- Chlorophenyl)isoindolinone; 3-(4-Chlorophenyl)-2,3-dihydro-1H- isoindol-1-one |
C14H10ClNO |
2224-77-3 |
|
| Diclazuril 6-Carboxamide (Impurity C)
Diclazuril 6-Carboxamide |
C18H10Cl3N5O3 |
1797132-12-7 |
|
| Apixaban methyl ester impuity
4,5,6,7-Tetrahydro-1-(4-hydroxyphenyl)-7-oxo-6-[4-(2-oxo-1-
piperidinyl) phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
C26H26N4O5 |
1074365-84-6 |
|
| Febuxostat Amide Impurity
2-(3-Carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5-
carboxylic acid |
C16H18N2O4S |
1239233-86-3 |
|
| Febuxostat Dicarboxylic Acid Impurity
2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5- thiazolecarboxylic acid |
C16H17NO5S |
1239233-87-4 |
|
| Fexofenadine EP Impurity C
Decarboxylated degradant |
C31H39NO2 |
185066-37-9 |
|
| (R)-Sitagliptin Methyl-Ester Impurity
methyl (R)-3-amino-4-(2,4,5-trifluorophenyl)butanoate |
C11H12F3NO2 |
881995-69-3 |
|
| Felbamate Related Compound A
3-hydroxy-2-phenylpropyl carbamate |
C10H13NO3 |
25451-53-0 |
|
| Cetirizine EP Impurity B
(RS)-2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]
acetic acid dihydrochloride |
C19H21ClN2O2 |
113740-61-7 |
|
| Vortioxetine Sulfoxide |
C18H22N2OS |
1429908-35-9 |
|
| Apixaban Impurity 2
ethyl (Z)-2-chloro-2-(2-(3-methoxyphenyl)hydrazono)acetate |
C11H13ClN2O3 |
405872-78-8 |
|
| Azilsartan Ethyl Ring-opening Impurity
ethyl(Z)-2-ethoxy-1-((2'-(N'- ((ethoxycarbonyl)oxy)carbamimidoyl)-[1,1'-biphenyl]-4- yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
C29H30N4O6 |
1403474-75-8 |
|
| Pregabalin EP Impurity C
2-hydroxy-2-phenylacetic acid,(Mandelic acid) |
C8H8O3 |
90-64-2 |
|
| Ketoprofen
2-(3-benzoylphenyl)propanoic acid |
C16H14O3 |
22071-15-4 |
|
| Metolazone EP Impurity A
Metolazone USP RC C ; meta-Metolazone ; |
C16H16ClN3O3S |
50869-25-5 |
|
| Bisoprolol EP Impurity Q
(2RS)-1-Isopropylamino-3-[4-(2-methoxyethoxy)methyl]- phenoxy-2-propanol |
C16H27NO4 |
1346604-00-9 |
|
| Fosfomycin Trometamol EP Impurity C
2-amino-3-hydroxy-2-(hydroxymethyl)propyl dihydrogen
phosphate |
C4H12NO6P |
23001-39-0 |
|
| Prasugrel HCl Desacetyloxy Impurity
1-cyclopropyl-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2- fluorophenyl)
ethan-1-one hydrochloride |
C18H18FNOS |
201049-78-7 |
|
| Fexofenadine Impurity 1
methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate |
C15H19ClO3 |
154477-54-0 |
|
| Albendazole EP Impurity B
Methyl [5-(propylsulphinyl)-1Hbenzimidazol-2-yl]
carbamate |
C12H15N3O3S |
54029-12-8 |
|
| Lansoprazole EP Impurity C
Lansoprazole USP Related Compound B ; Lansoprazole Sulfide |
C16H14F3N3OS |
103577-40-8 |
|
| Fosfomycin Trometamol EP Impurity A
(1,2-dihydroxypropyl)phosphonic acid |
C3H9O5P |
84954-80-3 |
|
| ROSUVASTATIN IMPURITY-K |
C22H26FN3O5S |
1422954-12-8 |
|
| Carbamazepine EP Impurity F
H-dibenzo[b,f]azepine-5-carbonyl chloride |
C15H10ClNO |
33948-22-0 |
|
| LURASIDONE DP5- IMPURITY
Lurasidone Sulfone |
C28H36N4O4S |
1644295-09-9 |
|
| Paracetamol EP Impurity J
N-(4-chlorophenyl)acetamide |
C8H8ClNO |
539-03-7 |
|
| Atenolol EP Impurity B
2-[4-[(2RS)-2,3-dihydroxypropoxy]phenyl]acetamide |
C11H15NO4 |
61698-76-8 |
|
| Pantoprazole Chloro Impurity
2-(chloromethyl)-3,4-dimethoxypyridine hydrochloride |
C8H11Cl2NO2 |
72830-09-2 |
|
| Brexpiprazole Impurity 3
5-Hydroxy-2(1H)-quinolinone |
C9H7NO2 |
31570-97-5 |
|
| Desloratadine
Desloratadine ; Loratadine USP RC A ; Loratadine EP Impurity D |
C19H19ClN2 |
100643-71-8 |
|
| Loratadine EP Impurity D
Desloratadine ; Loratadine USP Related Compound A |
C19H19ClN2 |
100643-71-8 |
|
| Phenoxymethylpenicillin EP Impurity B
Glycolic acid phenyl ether ; 2-phenoxyacetic acid |
C8H8O3 |
122-59-8 |
|
| Levodopa EP Impurity A
Levodopa USP Related Compound A ; (2S)-2-Amino-3-(2,4,5- trihydroxyphenyl)propanoic acid |
C9H11NO5 |
27244-64-0 |
|
| Nifedipine EP impurity A
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5- dicarboxylate (nitrophenylpyridine analogue) |
C17H16N2O6 |
67035-22-7 |
|
| Bumetanide EP Impurity A
Bumetanide Related Compound B ; 3-nitro-4-phenoxy-5-
sulfamoylbenzoic acid |
C13H10N2O7S |
28328-53-2 |
|
| Chlortalidone Impurity J
3-(4-chlorophenyl)-3-hydroxyisoindolin-1-one |
C14H10ClNO2 |
956-92-3 |
|
| Allopurinol EP Impurity C
Allopurinol USP RC C ; 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-
carboxamide |
C6H6N6O |
1346604-13-4 |
|
| Metoprolol Succinate
Bis[(2RS)-1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)- amino]propan-2-ol]
butanedioate |
2C15H25NO3.C4H6O4 |
98418-47-4 |
|
| Brimonidine EP Impurity C
Quinoxalin-6-amine |
C8H7N3 |
6298-37-9 |
|
